"Our findings," lead investigator Dr. Stuart G. Silverman told Reuters Health, "add further evidence to the growing body of knowledge that suggests that small renal cancers may be treated effectively using nonsurgical, interventional radiology techniques."
Dr. Silverman of Brigham and Women's Hospital, Boston and colleagues used the approach in 26 renal tumors (mean diameter, 2.6 cm) in 23 patients. In total, 24 of the tumors were renal cell carcinomas, one was transitional cell carcinoma and the other was an angiomyolipoma. Tumors were frozen using needle-like cryoprobes placed through the skin under MR imaging guidance.
"MR imaging was used throughout the procedure," continued Dr. Silverman, "using a specially designed, open MRI system that allowed interventional radiologists to view ice formation around the probe. This allowed almost all the tumors to be treated completely in one session."
Twenty-four tumors were successfully ablated and 23 required only one treatment session.
Follow-up was limited to approximately one year and "although this work is promising, longer follow-up will be need to fully establish its role in the treatment of renal cancer," Dr. Silverman pointed out.
However, he added that "MR imaging-guided percutaneous cryotherapy is being used at Brigham and Women's Hospital's Department of Radiology also to treat other types of tumors in locations throughout the body."
By David Douglas
Last Updated: 2005-08-05 11:24:18 -0400 (Reuters Health)
Radiology 2005;236:716-734.
Related Reading
Hepatic and renal MRI streamline preop organ donor tests, August 1, 2005
Copyright © 2005 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.